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Breast Cancer Referral and Screening Rates in a Federally Qualified Health Center:
Implementing the Point of Care Integrated Breast Cancer Screening Model
Jill C. Muhrer

CASE IN POINT:
Marta is a 52-year-old uninsured mother of 3 children who only comes into the
community clinic when she is ill. Her priority is her children, and she rarely finds time to
care for herself especially since she works as a housekeeper while her children are at
school. She recently went to the emergency room for shoulder pain where she was
diagnosed with tendonitis.
Rachel has been Marta’s nurse practitioner for years. She knows that Marta only
comes in for urgent issues and frequently reminds her to schedule her physical. She sees
Marta for follow up of her tendonitis, which has improved. She knows that Marta is due
for her mammogram but assumes that her gynecologist has ordered it. She is hesitant to
prolong the visit with preventive issues because she is running late, and Marta has to get
home to her children.
Later that month Marta’s gynecologist treats her for vaginitis and advises her to
schedule her annual because she is overdue for her pap and mammogram.
When Marta returns with worsening shoulder pain, Rachel does a breast exam,
and discovers a mass. She schedules her for an emergency mammogram, an appointment
with a surgeon and is devastated to learn that Marta has metastatic breast cancer.
BACKGROUND AND SIGNIFICANCE
Breast cancer is the most common cancer and the second leading cause of cancer
death in women in the United States1. In 2016, it is estimated that 246,660 women will
develop breast cancer and that 40,450 will die from it.1 Mammograms, by providing early
detection, reduce cancer related mortality by 20% for women of average risk.2 Despite
the effectiveness of screening, in 2013 only 65.9 % of women aged 45 and above had
completed a mammogram within 2 years .3 Mammogram utilization is lowest among
low-income (56.3%), uninsured women (39%), racial and ethnic minorities (60.8-69%),
women with a limited education (56%), and women without a primary care provider
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(29.7%).3,4,5,6 The consequences of not screening include delayed diagnosis, limited
treatment options, and decreased survival. 7,8,9
While breast cancer screening is a high priority, studies demonstrate that between
66-80% of eligible women report not receiving mammogram recommendations from
their clinicians. 10,11 Among low-income minority women with poor access to medical
care, the single most important factor cited for improving mammogram rates was
clinicians’ recommendations. 12,13,14,15 Even when women have full insurance coverage,
Medicare beneficiaries report a combination of inadequate information and lack of
provider recommendations as reasons for not obtaining mammograms. 16 In fact, four out
of ten women are not even aware that screening is covered under their plans. 6 Even when
Medicaid programs cover screening, Medicaid beneficiaries are less likely to be screened
than those with other types of insurance. 6
Federally qualified health centers (FQHC) provide comprehensive primary health
care to patients with Medicaid and to all people regardless of ability to pay and therefore,
offer critical safety net services to an underserved population.
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Facilitating contact with

a health care provider through increased reimbursement for office visits improves
screening rates in the Medicaid population.8 In a recent study, researchers noted that
when office visits were increased by 20%, there was a 2.2% increase in breast cancer
screening rates.8 This improvement was not associated with increased insurance
coverage, which only demonstrated inconsistent and minor improvements in breast
cancer screening.8 The researchers conclude that funding office visits may be a more
effective policy tool for improving cancer screening than screening test reimbursements.8
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The barriers that may interfere with health care providers making mammogram
referrals in FQHCs include competing priorities, high patient loads, limited resources, a
focus on acute care, and inadequate health insurance coverage. 17,18 Therefore, despite
good intentions, preventive care is often overlooked, which contributes to the gap
between recommended practice guidelines and their implementation.
CONCEPTUAL FRAMEWORK AND PRACTICE MODELS
In order to align preventive practices with clinical recommendations, the Institute
for Systems Improvement19 and the Healthy People 2020 Task Force 20 designate breast
cancer screening as a high priority. Furthermore, they recommend improving screening
rates by using evidence-based culturally appropriate, and patient-centered interventions to
improve screening at ALL clinic contacts regardless of whether the visit is for acute,
chronic, or preventive services. 19 Kaiser Permanente (KP), a large managed care
organization has implemented this proactive approach through its Complete Care model,
which was developed in 2004 to address gaps in clinical care for 26 chronic illnesses.21, 22
Based on a team approach, this model provides consistent evidence-based care by
offering treatment for chronic conditions and screening at every patient encounter.21 By
measuring national quality care indicators for chronic diseases beginning in 2005 through
2012, KP has demonstrated a 13.0% improvement in national quality care indicators for
25 illnesses.21 In addition, KP’s breast cancer screening rate among women aged 42-69
has improved by 2.7% from 85.6% in 2006 to 88.3% in 2009 .22
This proactive approach of integrating preventive services into all visits is
especially relevant for patients in FQHCs because often the patients in these settings
primarily focus on episodic visits for acute issues. In an analysis comparing preventive
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care receipt among patients of FQHCs versus patients of other settings, breast cancer
screening rates were higher (85%) at FQHCs than those at other practice settings (72%)
when providers addressed multiple issues at all visits. 23 Therefore, offering breast cancer
screening referrals at all patient office visits (the point of care) offers an excellent
opportunity for improving breast cancer screening rates.
While this approach makes sense from a clinicians’ viewpoint, there is also
evidence supporting patients’ openness to point of care preventive referrals. In a recent
study of hospitalized low-income women who were overdue for mammograms, 68%
stated that they would be willing to have mammograms in the hospital setting. 24
Furthermore, 91% of these women believed that it was important for health care workers
to discuss breast cancer screening with them during their hospital stay. 24 In a similar
study of hospitalized women from low socioeconomic backgrounds who were due for
mammograms, 72% stated that they would be willing to pay the additional cost of $83.41
for the convenience of inpatient mammogram screening. 25 These studies support
patients’ interest in obtaining mammograms within the context of episodic care including
acute care hospital settings.
Since patients have identified provider referrals as a key factor in determining
their rates of breast cancer screening, implementing a practice approach that supports the
patient provider relationship is critical to improving mammogram rates. The PatientCentered Medical Home (PCMH) is a model that focuses on patient-centered care,
enhanced access, and comprehensive patient care within a personalized team structure.
26,27,28

The key to the PCMH is to assign (also known as empaneling) a patient to a

specific provider who, with the support of a care delivery team (CDT) of support
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personnel, will provide comprehensive health care tailored to each patient’s needs and
preferences. 26,27 Implementation of the PCMH can improve both chronic and preventive
care. In a recent study, researchers noted that patients receiving care in PCMHs increased
their breast cancer screening rates by 5.4%, and this rate was the highest in practices
located in lower socioeconomic geographical areas.29 In addition, the strong relationships
that develop between patients and providers as a result of the PCMH are associated with
a higher use of preventive services.30
One of the first steps in the implementation of the PCMH is to empanel patients to
a provider and a CDT. 27 Once patients have a primary provider, there are specific
strategies that can be implemented to track and improve primary health care providers’
referral rates for their panels of patients. Since providers frequently overestimate their
screening rates, offering them direct feedback about their actual performance is one
measure that effectively generates more mammogram referrals. 31,32 In one study,
researchers measured the impact of educating physicians in underserved areas about the
American Cancer Society (ACS) guidelines for breast cancer screening, and determined
that these doctors almost doubled their mammogram referral rates. 33 Another
intervention to improve providers’ awareness is the use of both electronic medical
records (EMR) and the CDT to “flag” patients who are overdue for screening. 34 Utilizing
the CDT to implement practice tools such as chart prompts, tracking tools, and a
reminder system minimize barriers to screening by streamlining the visit and creating
more time for provider patient interactions. 35
Benefits from the expanded time frame for the patient provider relationship are
maximized with patient-centered communication that is culturally appropriate and in a
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language that patients understand. 27 The Cultural Explanatory Model (CEM) is a
framework based on the understanding that patients and health care providers may have
different cultural explanations of health and illness.36 Health care providers who are
guided by the CEM are more likely to encourage patient engagement in the screening
process.36 The CEM approach to breast cancer screening concentrates on developing a
mutual understanding of cultural definitions of breast health through its focus on
language, literacy, and knowledge of cultural context.36
Once a mutual understanding is achieved, this becomes the basis for integrating
patients’ values and preferences into a process of informed decision making about
mammogram screening. This approach, which has at its core the ethics of informed
consent, encourages patients to actively engage in decision making about breast cancer
screening. 37 In one recent study of medical decisions, the researchers found that while
78-85% of patients reported that providers made a recommendation, most patients were
not asked about their preferences regarding these recommendations. 38 Unfortunately, in
this same study only 20% of patients referred for breast cancer screening were asked for
their opinions. 38 Furthermore, patients with low-income or racial/ethnic minority
backgrounds often experience even less of a partnership with their providers and have
fewer discussions about cancer screening than nonminority affluent patients.39 Therefore,
providers in FQHCs need to be diligent about improving patient-centered quality of care
by utilizing the CEM and informed decision making models to avoid these disparities in
breast cancer screening.
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The Point of Care Integrated Breast Cancer Screening Model (PCISM)
In order to reduce the gap between evidence-based breast cancer screening
recommendations and current practice, the Point of Care Integrated Breast Cancer
Screening Model (PCISM) was developed to integrate these conceptual theories into a
systematic approach (Figure 1). According to PCISM, providers should refer eligible
patients for mammograms at the point of care, which means at any and all appointments
regardless of the reason for the visit. Integrating this approach through the PCMH model
improves breast cancer screening referrals by reinforcing the patient provider relationship
through the CDT, by improving patient- provider communication through the CEM
model, which also serves as a basis for shared decision making, and ultimately by
providing comprehensive high quality care.
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Figure One: The Point of Care Integrated Breast Cancer Screening Model
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OBJECTIVES
The purpose of this practice improvement project was to increase mammogram
referral and screening rates at a FQHC. The specific aims were to analyze the literature
to determine the source of the gap between evidence-based recommendations and clinical
practice, to develop and implement an evidence-based integrated breast cancer screening
and referral model (the PCISM) to provide effective point of care referrals for breast
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cancer screening, and to compare mammogram referral and screening rates between
providers who adopted PCISM and those did not adopt PCISM.
METHODS
Setting and sample
The setting was an urban FQHC in New Jersey that provides primary care to an
ethnically diverse patient population (87.3% minority) of 37,380 where 96.2% of the
patients live below 200% of the poverty level and 27.7% are uninsured. 40
The sample included 8 internal medicine (IM) providers who were classified
according to their selection of either the PCISM or the conventional model of
mammogram referrals. The conventional providers (3 physicians and1 nurse practitioner)
made mammogram referrals only during preventive care visits while the PCISM
providers (2 physicians and 2 nurse practitioners) provided mammogram referrals at all
appointments regardless of the type of encounter. Both groups shared the common goal
of referring all women of average risk for annual mammograms starting at age 40 and for
as long as the benefits outweighed the risks.
Procedures
Since the FQHC clinical department had selected increased mammogram referral
and screening rates as its clinical goal, the informational technology (IT) department
provided individual statistics on these rates for all IM providers at monthly staff meetings
over the 24 months of the program evaluation. These de-identified rates served as
outcome measures for the program evaluation.
Because this project did not include specific patient or provider information, and
practitioners were not identified in the screening and referral rate data, the project design
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did not represent human subjects research, and an exemption by the Human Subjects
Research Review Committee was granted.
Data Analysis
Providers identified solely by a number code were classified into two groups
according to their selection of either the PCISM or the conventional model of
mammogram referrals. Frequency data for providers’ screening and referral rates were
collected from the introduction of the PCISM in January 2014 through December 2015.
These data were analyzed with the chi2-test to determine whether there was a difference
in the frequency (number) of mammogram screenings and referrals rates between the
providers who used the PCISM versus those who used the conventional model. Baseline
rates were recorded, and monthly referral and screening rates were reviewed and
analyzed as outcome measures.!
RESULTS
The differences in the mean number of patients referred for mammograms and the
mean number of patients with completed mammograms between the PCISM group and
the conventional group are displayed in Figures 2 and 3. The chi2 analyses for referral
and screening rates are presented in Tables 1 and 2.
Figures 2 and 3 display the screening and referral trends for the two groups by
quarters. During three quarters, the referrals dropped noticeably particularly among the
PCISM providers, and these periods of reduced referrals corresponded with specific
stressors in the organization. During the fourth quarter of 2014, the mean number of
referrals for PCISM providers dropped from 92-74, which coincided with the
discontinuation of the FQHC’s on site free mammogram screening service due to lack of
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funding. This trend reversed during the first quarter in 2015 when free mammograms
were offered through a program at a local hospital. During the second quarter of 2015,
referrals declined again when there was a shift of resources and staffing away from breast
cancer screening to a new fully funded program to reduce unnecessary emergency and
hospital visits. The agency also experienced staff resignations during this time, which
presented challenges for the PCMH teams. The decline in the mean number of
mammogram referrals (96-86) occurred during the fourth quarter of 2015, which
coincided with leadership changes, and a new policy to increase each provider’s schedule
by 30%. Despite these challenges, the PCISM providers maintained a mean number of
referrals throughout the 24 months that ranged from 70.8-96.8 per quarter as compared to
the conventional group whose mean referrals ranged from 37.3-54.
Figure%2:%Comparison%of%Mean%Number%of%Mammograms%
Ordered%between%PCISM%and%Conventional%Providers%
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80.0+
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Interestingly, the number of patients screened did not reflect the same variations
that were noted in the referrals. Furthermore, both the PCISM and conventional groups
had more consistent patterns over time. The mean number of patients screened for the
PCISM group ranged from 39.4% to 53.8% with a steady trend upwards while the
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conventional providers’ mean numbers ranged from 10.3% to 23% also with an overall
upward trend. While referrals are primarily the responsibility of the providers, it is the
patients who influenced screening patterns because they controlled whether or not the
mammogram was completed. Patient participation in the screening process through
shared decision making, and self-management could have contributed to higher screening
success in the PCISM group. It is encouraging that the conventional providers’ screening
patterns consistently increased over time, which could have been related to an indirect
diffusion of the PCISM approach to screening.

Figure%3:%Comparison%of%Mean%Screening%Rates%between%PCISM%
and%Conventional%Providers%
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The Chi square analysis demonstrates a statistically significant difference between
the PCISM and the conventional clinicians’ referral and screening outcomes. During the
24-month project, a total of 9477 women were identified as being eligible for
mammography. The PCISM providers cared for 5760 women while the conventional
providers cared for the remaining 3717 women. In the PCISM group, 2444 women
(42%) had received mammograms versus 581 (16%) in the conventional group. This
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difference was statistically significant (p=<0.001) and therefore lends support to the
effectiveness of the PCISM approach to screening (see Table 2). There was also a
statistically significant difference (p=<0.001) in referral rates between the intervention
group (43%) and the control group (37%), which suggests a similar advantage of PCISM
for improving mammography referrals (see Table 1).
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Table 1.
Comparison of Mammograms Ordered Between Intervention and Control Group (n = 9477)
Group
Variable
Response
Total
P value

Mammogram ordered
in past 24 months
•

Yes
No

Intervention
(n = 5760)

Control
(n = 3717)

2451 (43%)
3309 (57%)

1409 (37%)
2308 (63%)

3860
5617

< 0.001*

p < 0.05(two-tailed), Chi-Square Test (1, n = 9477) =20.1
!

!

Table 2.
Comparison of Mammograms Performed Between Intervention and Control Group (n = 9477)
Group
Variable
Response
Total
P value
Intervention
(n = 5760)

Control
(n = 3717)

Mammogram done in
past 24 months

Yes
2444 (42%) 581 (16%)
No
3316 (58%) 3136 (84%)
* p < 0.05(two-tailed), Chi-Square Test (1, n = 9477) = 746.7

3025
6452
!

< 0.001*

!
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DISCUSSION AND IMPLICATIONS FOR PRACTICE
The PCISM with its emphasis on point of care referrals, the PCMH, and the
inclusion of patients’ cultural beliefs in patient centered decision making, offers a
promising approach to improving breast cancer screening in FQHCs. As a result of the
program evaluation, the IM department has implemented the PCISM approach with all
providers. In addition the model will be expanded to include colon cancer screening. In
order to improve the efficiency of PCISM, the clinical team has made the following
revisions to the model: the CDT performs anticipatory visit planning to ensure that
screening results are in the EMR to flag patients due for screening, and screening orders
are placed in the patient’s chart prior to the visit. During the day of the appointment, the
CDT provides a written summary detailing each patient’s needs, which is shared with the
provider at morning team meetings so that strategies for implementing these orders can
be reviewed. Providers are then able to focus on other priorities and merely need to sign
the orders to validate them. The IT department is developing a system to interface
screening results onto a flow sheet where the data can be captured and utilized for
tracking. This approach provides screening feedback to providers and also identifies
patients for outreach purposes.
In the future, it would be helpful to include patients more directly in the PCISM
process by soliciting feedback on effective screening measures, and by engaging them
with more community outreach. Future work includes developing and testing a culturally
relevant shared decision making tool for discussion of screening issues with patients.
This tool will focus on evaluating individual risk factors, patients’ values, and a review of
the risks and benefits of mammography within the context of the individual patient. Other
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strategies to meet patients’ preferences will include offering flexible screening schedules
such as same day appointments, appointments close to the referral time, and patient
selected reminder systems that would reinforce appointment times. Continued successful
use of health fairs that focus on breast care as an important component of women’s health
and that include families and friends also promote community outreach.
LIMITATIONS
Because the PCISM group and the conventional group of health care providers
were self-selected rather than randomly assigned, and also because the two groups
consisted of a different balance of provider types (i.e. physicians and nurse practitioners),
it is possible that the differences in outcomes between the two groups may have been
biased. The small sample size of providers in addition to the single study setting in one
FQHC further limits the generalizability of the results to other practice settings with
different types of staffing. Although the sample size of patient encounters was robust
(9477), specific population characteristics such as demographics and disease burden were
not collected which made it impossible to analyze similarities and differences between
the groups. These factors could have had an independent influence on screening rates
that were not related to the intervention and in future research demographic description of
patient cohorts could be added. Finally, since the EMR system did not automatically
capture screening rates, providers had to enter them manually. Therefore, even though
providers in both groups stated that they consistently entered the data, the screening
results could have been affected by omissions in data entry.
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FUTURE INITIATIVES
The next step in the implementation of the PCISM model is to focus on the
tracking and follow up of women with abnormal mammogram findings. This directive
will help these patients complete the diagnostic process and will support early treatment
of those women diagnosed with breast cancer.
CONCLUSION
Breast cancer is a leading cause of cancer morbidity and mortality in women that
can be reduced with appropriate screening. While many factors influence screening rates
in underserved populations, the number one factor that women cite for not obtaining a
mammogram is the lack of a recommendation from their provider. Providers, especially
those in busy FQHCs, often struggle with obstacles to screening such as a high volume of
acute visits, agenda overload, and limited time. The findings of this small program
evaluation suggest that the use of PCISM can improve mammography referral and
screening rates in FQHCs, and in doing so, can translate evidence-based
recommendations into preventive clinical practices that can ultimately save lives through
early detection and treatment.
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